Načítá se...
Fast-track drug approval in inflammatory bowel diseases
Fast-track drug designation of safe regimens represents an emerging method of development and approval of new medications targeting debilitating diseases including inflammatory bowel diseases (IBD). The goal of accelerated drug approval pathways is to shorten the time between application and approva...
Uloženo v:
| Vydáno v: | Ann Gastroenterol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hellenic Society of Gastroenterology
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5049549/ https://ncbi.nlm.nih.gov/pubmed/27708508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20524/aog.2016.0051 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|